News Summary

Elon Musk’s startup Neuralink, a neurotechnology company, has successfully raised $600 million in a funding round that values the company at $9 billion pre-money. This marks a significant increase from its $5 billion valuation in June 2023. The funding follows the company’s achievement of receiving the ‘breakthrough device’ clearance from the U.S. FDA. Neuralink has already implanted devices in three patients, including a nonverbal patient who uses the implant for activities such as editing and narrating YouTube videos through brain signals. The company aims to continue advancing brain-machine interface technology.